Kamran Alam

Chief Financial Officer at Taysha Gene Therapies

Kamran Alam is a finance executive with experience with follow-on financings and M&A, served as VP Finance at AveXis where he played a key role in the acquisition of AveXis by Novartis, most recently served as SVP Finance and Principal Financial Officer at Rocket Pharma.

Links

Org chart

Teams

+3

CEO and Executive Team

6 members

+3

Leadership Team

6 members

Timeline

  • Chief Financial Officer

    Current role

View in org chart